Yumiko Hirokawa

1.6k total citations
31 papers, 910 citations indexed

About

Yumiko Hirokawa is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yumiko Hirokawa has authored 31 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yumiko Hirokawa's work include Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Yumiko Hirokawa is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Yumiko Hirokawa collaborates with scholars based in Australia, Japan and United States. Yumiko Hirokawa's co-authors include Hiroshi Maruta, Antony W. Burgess, Chin Wee Tan, Hong He, David W. Smith, Bruce S. Gardiner, Thao Nheu, Meredith J. Layton, John L. Wood and John Zalcberg and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Yumiko Hirokawa

31 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumiko Hirokawa Australia 19 528 271 106 90 86 31 910
Jiuxiang Zhu United States 11 576 1.1× 161 0.6× 67 0.6× 162 1.8× 40 0.5× 11 1.0k
Paolo Bonvini Italy 16 721 1.4× 229 0.8× 91 0.9× 61 0.7× 58 0.7× 34 1.0k
Lluís López-Barcons United States 16 742 1.4× 305 1.1× 103 1.0× 44 0.5× 46 0.5× 44 1.3k
Mayuko Omori United States 10 883 1.7× 294 1.1× 70 0.7× 67 0.7× 19 0.2× 14 1.2k
Barry J. Maurer United States 17 1.0k 1.9× 164 0.6× 128 1.2× 69 0.8× 293 3.4× 40 1.3k
Lance R. Thomas United States 20 1.0k 1.9× 230 0.8× 87 0.8× 47 0.5× 42 0.5× 25 1.2k
Chul‐Woong Chung South Korea 12 829 1.6× 306 1.1× 170 1.6× 39 0.4× 36 0.4× 20 1.1k
Sourav Banerjee United Kingdom 16 653 1.2× 180 0.7× 177 1.7× 136 1.5× 31 0.4× 33 973
Thomas P. Garner United Kingdom 19 958 1.8× 161 0.6× 170 1.6× 98 1.1× 70 0.8× 29 1.3k
Sally A. Prigent United Kingdom 16 775 1.5× 483 1.8× 188 1.8× 41 0.5× 30 0.3× 23 1.3k

Countries citing papers authored by Yumiko Hirokawa

Since Specialization
Citations

This map shows the geographic impact of Yumiko Hirokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumiko Hirokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumiko Hirokawa more than expected).

Fields of papers citing papers by Yumiko Hirokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumiko Hirokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumiko Hirokawa. The network helps show where Yumiko Hirokawa may publish in the future.

Co-authorship network of co-authors of Yumiko Hirokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yumiko Hirokawa. A scholar is included among the top collaborators of Yumiko Hirokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumiko Hirokawa. Yumiko Hirokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirokawa, Yumiko, Michelle Palmieri, Tao Tan, et al.. (2021). Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine. Communications Biology. 4(1). 1067–1067. 30 indexed citations
2.
Ho, Gwo‐Yaw, Mark Scott, Chin Wee Tan, et al.. (2021). Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1−/− mice. Cell Death and Disease. 12(12). 1091–1091. 2 indexed citations
3.
Luo, Mingjie, Michelle Palmieri, Chris Riffkin, et al.. (2020). Defining the susceptibility of colorectal cancers to BH3-mimetic compounds. Cell Death and Disease. 11(9). 735–735. 13 indexed citations
4.
Yip, Hon Yan Kelvin, Chin Wee Tan, Yumiko Hirokawa, & Antony W. Burgess. (2018). Colon organoid formation and cryptogenesis are stimulated by growth factors secreted from myofibroblasts. PLoS ONE. 13(6). e0199412–e0199412. 23 indexed citations
5.
Tan, Chin Wee, Yumiko Hirokawa, & Antony W. Burgess. (2015). Analysis of Wnt signalling dynamics during colon crypt development in 3D culture. Scientific Reports. 5(1). 11036–11036. 12 indexed citations
6.
Hirokawa, Yumiko, Hon Yan Kelvin Yip, Chin Wee Tan, & Antony W. Burgess. (2014). Colonic myofibroblast cell line stimulates colonoid formation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 306(7). G547–G556. 27 indexed citations
7.
Tan, Chin Wee, Bruce S. Gardiner, Yumiko Hirokawa, David W. Smith, & Antony W. Burgess. (2014). Analysis of Wnt signaling β-catenin spatial dynamics in HEK293T cells. BMC Systems Biology. 8(1). 44–44. 23 indexed citations
8.
Tan, Chin Wee, Yumiko Hirokawa, Bruce S. Gardiner, David W. Smith, & Antony W. Burgess. (2013). Colon Cryptogenesis: Asymmetric Budding. PLoS ONE. 8(10). e78519–e78519. 31 indexed citations
9.
Hirokawa, Yumiko, Alexander Levitzki, Guillaume Lessène, et al.. (2006). Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors). Cancer Letters. 245(1-2). 242–251. 30 indexed citations
10.
Hirokawa, Yumiko, et al.. (2006). Sichuan pepper extracts block the PAK1/Cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice. Cancer Biology & Therapy. 5(3). 305–309. 30 indexed citations
11.
Hirokawa, Yumiko, C. Oliver Hanemann, Armin Kurtz, et al.. (2005). Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biology & Therapy. 4(4). 385–387. 30 indexed citations
12.
Hirokawa, Yumiko, et al.. (2005). Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance. Cancer Biology & Therapy. 4(9). 956–960. 66 indexed citations
13.
Shimauchi, Takatoshi, Yumiko Hirokawa, & Y. Tokura. (2005). Purpuric adult T-cell leukaemia/lymphoma: expansion of unusual CD4/CD8 double-negative malignant T cells expressing CCR4 but bearing the cytotoxic molecule granzyme B. British Journal of Dermatology. 152(2). 350–352. 12 indexed citations
14.
He, Hong, Yumiko Hirokawa, Aviv Gazit, et al.. (2004). The Tyr-Kinase Inhibitor AG879, that Blocks the ETK-PAK1 Interaction, Suppresses the RAS-induced PAK1 Activation and Malignant Transformation. Cancer Biology & Therapy. 3(1). 96–101. 31 indexed citations
15.
Haginoya, Noriyasu, et al.. (2004). Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(11). 2935–2939. 16 indexed citations
16.
Haginoya, Noriyasu, Satoshi Komoriya, Toshiharu Yoshino, et al.. (2004). Design, synthesis, and biological activity of non-amidine factor Xa inhibitors containing pyridine N-oxide and 2-carbamoylthiazole units. Bioorganic & Medicinal Chemistry. 12(21). 5579–5586. 27 indexed citations
17.
Nheu, Thao, Hong He, Yumiko Hirokawa, et al.. (2002). The K252a Derivatives, Inhibitors for the PAK/MLK Kinase Family, Selectively Block the Growth of HAS Transformants. The Cancer Journal. 8(4). 328–336. 56 indexed citations
18.
Tamaki, Kazuhiko, J. Brad Shotwell, Ryan D. White, et al.. (2001). Efficient Syntheses of Novel C2‘-Alkylated (±)-K252a Analogues. Organic Letters. 3(11). 1689–1692. 21 indexed citations
19.
Komiyama, Kanki, Yumiko Hirokawa, Hiroko Yamaguchi, et al.. (1987). Antitumor activity of trienomycin A on murine tumors.. The Journal of Antibiotics. 40(12). 1768–1772. 12 indexed citations
20.
Komiyama, Kota, et al.. (1986). [The suppressive effect of pyrrole-2-carboxylic acid on platelet aggregation].. PubMed. 39(3). 746–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiuxiang Zhu Breakdown of academic impact, for papers by Paolo Bonvini Breakdown of academic impact, for papers by Lluís López-Barcons Breakdown of academic impact, for papers by Mayuko Omori Breakdown of academic impact, for papers by Barry J. Maurer Breakdown of academic impact, for papers by Lance R. Thomas Breakdown of academic impact, for papers by Chul‐Woong Chung Breakdown of academic impact, for papers by Sourav Banerjee Breakdown of academic impact, for papers by Thomas P. Garner Breakdown of academic impact, for papers by Sally A. Prigent
Rankless by CCL
2026